Robert A. Cambria
Papers
4
Total Citations
58
H-Index
4
About
Robert A. Cambria’s research has focused on the intersection of cigarette smoke exposure and vascular health, particularly how smoking and hypercholesterolemia impair endothelial function—a key early step in atherosclerosis. His most cited work, “Ascorbic Acid Prevents Cigarette Smoke Injury to Endothelium-Dependent Arterial Relaxation” (1999, 34 citations), demonstrated that antioxidant treatment could protect blood vessels from smoke-induced damage, offering a potential preventive strategy. In a landmark study, “Smoking Cessation Reverses Arterial Endothelium-Dependent Relaxation Injury” (1998, 6 citations), Cambria showed that stopping smoke exposure could restore normal vessel relaxation in rabbit models, providing early experimental evidence that endothelial dysfunction from smoking is reversible. His other studies, including “Combined exposure to cigarette smoke and hypercholesterolemia decreases vasorelaxation of the aorta” (1997, 11 citations), explored how multiple risk factors synergistically harm arterial function. Cambria’s work has been cited over 58 times, contributing foundational insights into the mechanisms of smoking-related vascular injury and the potential for reversal through cessation or antioxidants.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4